A comprehensive analysis of European biotech

<p><span data-contrast="auto">The latest episode of the free DDW podcast is titled “</span><span data-contrast="none">A comprehensive analysis of European biotech</span><span data-contrast="auto">”. It covers three narrated articles written for Volume 22, Issue 3 – Summer 2021 of DDW, read by Megan Thomas.</span> <span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}">  </span></p> <p><span data-contrast="auto">The articles are “Innovation and opportunity within Europe’s biotech sector”, “Europe’s emerging biotechs: Challenges, opportunities and funding”, and “Why Switzerland continues to punch above its weight as global biotech hub”.</span><span data-ccp-props= "{"201341983":0,"335559739":160,"335559740":259}"> </span></p> <p><span data-contrast="auto">In the first article, Lu Rahman introduces a slice of European biotech expertise. In the second, John Macdonald of ICON examines the European biotech sector’s expertise, opportunities and potential for growth. In the third, Lu Rahman spoke to Michael Altorfer of the Swiss Biotech Association, Jan Lucht of scienceindustries, Claude Joris of BioAlps, and Carole Delauney of swiss</span></p>